All of script bridge peptides are manufactured in the US.
Certificates of authenticity apply to research peptides, and script bridge does not sell these. script bridge sells prescription peptides only. Online legitimacy for companies that sell prescription peptides is validated through platforms like LegitScript, not certificates of authenticity. Unlike research peptides, prescription peptides are dispensed through licensed pharmacies with FDA-compliant ingredient sourcing and are prescribed by a licensed provider.
Yes, we do this for every pharmacy we partner with. Each pharmacy undergoes a thorough vetting process before we enter a contract with them. One of our key requirements is that they must provide certificates of analysis and third-party laboratory testing upon request. This ensures script bridge patients receive high-quality, independently tested medications they can trust.
No, the FDA doesn’t “approve” compounded medications because they aren’t mass-manufactured products. Compounded drugs vary by pharmacy, batch, and patient, so there isn’t one fixed product for the FDA to evaluate and approve in the traditional way. Instead, the U.S. Food and Drug Administration regulates the practice framework (through 503A and 503B pathways) and oversees safety and quality standards, while state pharmacy boards regulate day-to-day compounding operations.
The FDA approval process is designed for standardized drugs produced at scale, where the agency reviews large clinical trials, manufacturing consistency, labeling, and long-term stability data.
The FDA regulates the framework and safety compliance, but compounded drugs themselves are not FDA-approved products.
The FDA approval process is designed for standardized drugs produced at scale, where the agency reviews large clinical trials, manufacturing consistency, labeling, and long-term stability data.
If you’re new to Scriptbridge or have not previously used compounded semaglutide or tirzepatide (or are transitioning from a brand-name medication), we highly encourage you to choose the titration plan to avoid running out before the end of your 3 months. A titration plan gives your doctor the flexibility to safely adjust your dose as your body responds, without putting you at risk of running out of medication.
In most cases, it’s not recommended to receive three months of the same dose when starting treatment. This is because, if your provider needs to increase your dose in month two, taking a higher dose from a fixed three-month supply could cause you to run out sooner than expected.
With a titration plan, if your next month is prescribed at a higher strength but you need to remain at your current dose, your provider can adjust your dosing instructions so you take a smaller amount of the higher-strength medication. This allows your supply to last appropriately while maintaining the correct dose for your treatment plan.